Confused by the 🚩on your patients CBC?
A (pediatric) hematology primer
-Thrombocytosis (high platelets) is reactive 99.9999% of the time. Think iron deficiency, infections. Hematologists rarely get excited until it’s multiple millions.
1/
Overall, this review highlights the limited evidence supporting the use of anti-Xa monitoring for dose adjustments in the therapeutic use of low-molecular-weight heparins. Therefore, we conclude that measuring anti-Xa levels is currently not justified. @jthjournal.bsky.social
Check out the latest @jthjournal.bsky.social "JTH in Clinic" article providing clinicians w/real-world tools to manage gynecologic bleeding in patients on anticoagulation. Published in collab w/the Found. for Women & Girls w/Blood Disorders, it offers assess. & treatment guidance,
bit.ly/4oOoD1N
New treatments have greatly improved survival for #cancer patients but they also come with a risk of #thrombosis. In our new review in @jthjournal.bsky.social we explain why.
doi.org/10.1016/j.jt...
@wardm6tcd.bsky.social @isth.org.
💡The @isth.org #SSC has been busy - dont miss the latest SSC
✅communications
✅guidance
✅guidelines
published in @jthjournal.bsky.social :
ℹ️https://bit.ly/4p1GYZz
Excited to share this article highlighting the important role of Antithrombosis Stewardship to improve Safe Transitions of Care in pts with VTE.
#Stewardship #Anticoagulation #AntithromboticStewardship #TransitionsofCare
@jthjournal.bsky.social @isth.org
www.sciencedirect.com:5037/science/arti...
🚨 New RPTH Journal Research Recap! Dive into the latest insights from recent articles.
Read ahead:
📄 Full article → lnkd.in/eRJQcZEV
💬 Commentary → lnkd.in/g-q5ZvAa
Register here: streamyard.com/watch/WB9QYXi3e3hH
This Research Recap is supported by an educational grant from Takeda.
🚀 AI vs. Thrombosis Experts: Who performs better?
New study shows: AI models deliver patient education answers that are often rated better than experts — and perform similar in complex clinical cases.
@nikola-vladic.bsky.social @jeanconnorsmd.bsky.social @jthjournal.bsky.social
🤖🩸 #ArtificialIntelligence in everyday clinical practice: A study by #MedUniVienna shows that language models sometimes provide better answers than experts when it comes to questions about #venousthromboembolism. ⬇️
📰 Results in @jthjournal.bsky.social
ISTH is partnering with Inari, now a part of Stryker, for #WorldThrombosisDay 2025! Together we’re advancing #VTE care through a new educational offering:
🎧 The Role of Mechanical Thrombectomy in Transforming VTE Care
Launching Oct 16 on the ISTH Pulse Podcast.
🔗 www.worldthrombosisday.org
JTH is proudly supports @worldthrombosisday.bsky.social! Show your commitment to patient safety and awareness this #WorldThrombosisDay on October 13. Share this graphic or create your own image using the WTD Design Hub: www.worldthrombosisday.org/poster-builder/ #WTDay25
The ISTH proudly recognizes Global #ITP Awareness Week 💜This year’s campaign theme, "Shining a light on ITP," underscores the importance of visibility and community engagement. #PaintThePlanetPurple #LightUp4ITP
🟣ISTH members: The ISTH offers educational resources about ITP here lnkd.in/debX39MC
1/ 📣 New risk calculator for stroke prediction in #AFib
♥️ Two #REGARDSStudy manuscripts in @jthjournal.bsky.social
♥️ One Identified biomarkers for breakthrough stroke
♥️ In the other we developed a new CHADS-VASc-Biomarkers score
@samnotshort.bsky.social
go.uvm.edu/strokecalc
@jthjournal.bsky.social commentary in the most recent issue about more VTE prevention is needed in pregnancy - www.jthjournal.org/article/S153...
It will be interesting to see what the new UK 37a green top guidelines advise in the Autumn
💡Turn your exciting research into high-impact publications!
Whether you presented at #ISTH2025 &/or have some other new & exciting science to share, watch this interview w/our editors & learn more about submitting to @ISTH.org @jthjournal.bsky.social or @rpth.bsky.social
bit.ly/46TLcfk
📢📢NEW research from @jthjournal.bsky.social!
Two new papers were released on stroke risk and prediction in #atrialfibrillation. Whether you’re a clinician or researcher, you won’t want to miss these insights. Visit jthjournal.org to explore this new research. #stroke #afib #af
Our webinar with Dr. Jean M. Connors has been rescheduled to August 1st!
Don’t miss this opportunity to hear from a top expert in the field!
#ISTH2025 #Hematology #MedicalEducation #ClinicalHematology @ash.hematology.org @isth.org @jthjournal.bsky.social @athnnews.bsky.social
📚Spotlight on ISTH publications at #ISTH2025:
✅ @rpth.bsky.social: As ISTH’s open-access, online-only journal, RPTH is drives innovation & accessibility in science.
✅ @jthjournal.bsky.social: JTH publishes peer-reviewed groundbreaking research, reviews & clinical guidance
Learn more: bit.ly/4k5PbID
If you want to learn more about Factor XI inhibitors, check out this recent review article in @jthjournal.bsky.social
pubmed.ncbi.nlm.nih.gov/39675564/
Global EHR-based study shows ~6% of children with CHD develop VTE within a year post-surgery, with a 25% recurrence rate. Most cases involved LE-DVT. Highlights need for targeted thromboprophylaxis strategies in this high-risk population. #PedsCardio #Thrombosis www.jthjournal.org/article/S153...
Amazing and thorough discussion on the ISTH Hemophilia Guidelines contents & methodology live at #ISTH2025
See this paper in JTHfor more deconstruction of the guidelines #hemophilia #hemesky
www.jthjournal.org/article/S153...
Meta-analysis on GLP-1RA (vs. placebo) and VTE:
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
The @rpth.bsky.social and @jthjournal.bsky.social Editors presented the Editors awards this afternoon, including this one to Daniel Steiner.
Corticosteroids remain the go-to for managing transaminitis post-valoctocogene roxaparvovec in hemophilia A. Early, reactive treatment may help preserve FVIII levels. #GeneTherapy #HemophiliaA #HemeSky www.jthjournal.org/article/S153...
Interesting discussion on high open access fees, increase of high quality papers from China & usage of Generative AI. More tools are needed #isth2025 @isth.org @jthjournal.bsky.social @rpth.bsky.social
And we're off #isth2025
EIC Ton Lisman @jthjournal.bsky.social introduces key points! Follow them on @linkedin.com
Considerations for use of generative AI in publication presented at the Publication Session #ISTH2025 @jthjournal.bsky.social
Find the @rpth.bsky.social and @jthjournal.bsky.social editors in PUB01 - The evolving landscape of academic publishing!
📍Room 151 A&B
⏰ 10:30-11:30
🗣️ @profmakris.bsky.social, Ton Lisman and Suzanne Cannegieter with host Donna DiMichele
🩺 In the PAUSE-2 pilot trial, perioperative management of DOACs in patients undergoing high-bleed-risk surgery or neuraxial procedures was found feasible. Both ASRA- and PAUSE-based strategies achieved similar pre-op DOAC levels, supporting a larger trial.
www.jthjournal.org/article/S153...
